W STRATEGIES, LLC for ABBVIE INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3723: Viral Hepatitis Testing Act. Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).Education about the value of innovative new medicines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
Monitored legislative efforts to reform the corporate tax system. S. 2360/H.R. 4679: Stop Corporate Inversion Act of 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.